This blog is an update for those who have been following my posts on the Belly Button Biodiversity Project. I hadn't heard anything further from the team, until I received the email below. Now the important question: Did I put my new address on my request?
Dear Belly Button Biodiversity Enthusiast,
Great to hear from you!
We've had a tremendous amount of interest in our project, and well, because we're a team of humans and not robots, we've been overwhelmed by the sheer number of requests we've received for sampling kits.
Rest assured, we have your contact info and will be sending out sampling kits as soon as we can, most likely within the next few weeks. We appreciate your patience, as we're just as excited to learn about the microbes living in your navel as you are!
While you're waiting, check out some of the exciting articles and news affiliated with belly buttons and the other wildlife inhabiting our homes and bodies: http://www.yourwildlife.org/ And don't forget to like our Facebook page!
Best,
The Belly Button Biodiversity Team
http://www.wildlifeofyourbody.org/
A writer's thoughts on writing, science, reading, public health, science fiction, and a few other ramblings.
Thursday, October 13, 2011
Update from the Belly Button Biodiversity Team
Labels:
bacteria,
belly button,
science
Monday, October 10, 2011
Post-move update: New home and randomness
| Sunset over the lake |
Our move is almost complete. Most of the remaining delay is lack of time without toddler assistance. (Though the endeavor has not been aided by assorted colds and tummy troubles.) A few items remain at the apartment, but we're gradually clearing those out as opportunity presents to take a trip here and there. Unpacking continues at the house. At the current rate, I estimate at least a month before we dismantle the mountain of boxes. Even that may be optimistic. We take a bit of time each day just to appreciate the beauty of our new home, like the view of the sunset over the lake.
| Fun in the back yard |
Fortunately, my packed weekend started on Friday. While waiting for the shop to finish repairs to our secondary vehicle, hubby and I used our primary vehicle to ran errands that resulted in the purchase of a couple of ottoman/table combos for the living room and elements for my son's new space-themed room. We also completed his Halloween costume and found bigger footie pajamas. I took my son to Sabbath School and my cat to the vet. I enjoyed an all-too-brief visit from my siblings and their families, went grocery shopping, and a stopped by the apartment for my vacuum cleaner and carefully-wrapped wedding gown.
I'm limping along on my old computer, which happened to be the one accessible when we set up our Internet, and planning to dig out the newer computer this weekend.
Currently reading:
A quote for thought, from the first-listed book above:
"...writing is all about getting happy. Writing is never a hobby. Neither is it a dilettante activity for which we salvage some leftover time from our otherwise busy days. Writing feeds those days. On the days when I don’t write, I underperform as an employee and as a human being.
In fact, I think my boss or the U.S. government should pay me for the time I spend at home with my morning coffee and my journal. That—not the conference-room pep talks—makes me a happier, more focused employee.
I write. Therefore I work. Simple as that."
Labels:
family,
personal,
randomness
Monday, October 3, 2011
The beginning of the end for the flu virus?
Vaccines have been the weapon of choice against viruses, and I have talked about them here on several occasions. Now research is exploring a new therapy: an antiviral drug called Double-Stranded RNA Activated Caspase Oligerizer (DRACO). Catchy name aside, what does DRACO do? It targets cells that have been infected by a virus, hunting the signature mechanism by which viruses reproduce.
Still with me? In short, DRACO targets cells with long strings of double-stranded RNA, causing them to commit cell suicide while ignoring the other healthy cells.
Dr. Rider's research has been tested on 15 different viruses, including H1N1 influenza, and it was effective against them all. The possible catch is that this research was primarily conducted on mammalian cells cultured in a lab, which leaves the possibility that the drug might not work on living animals. More recent work on the drug's effect on mice infected with influenza has continued to yield promising results.
If perfected, DRACO could revolutionize the treatment of viral diseases. Vaccines are effective, until the virus mutates. An antiviral drug could continue to work when vaccines fail. More research and time is needed to determine whether the new treatment is safe and effective for treating viral infection in humans.
- Fixation and entry of the virus into the targeted cell.
- Copy the genes of the virus using the cell’s power.
- Bundling of virus particles.
- Emergence of many copies of the new virus to spread the infection to other cells.
Still with me? In short, DRACO targets cells with long strings of double-stranded RNA, causing them to commit cell suicide while ignoring the other healthy cells.
Dr. Rider's research has been tested on 15 different viruses, including H1N1 influenza, and it was effective against them all. The possible catch is that this research was primarily conducted on mammalian cells cultured in a lab, which leaves the possibility that the drug might not work on living animals. More recent work on the drug's effect on mice infected with influenza has continued to yield promising results.
If perfected, DRACO could revolutionize the treatment of viral diseases. Vaccines are effective, until the virus mutates. An antiviral drug could continue to work when vaccines fail. More research and time is needed to determine whether the new treatment is safe and effective for treating viral infection in humans.
Labels:
public health,
vaccine,
virus
Subscribe to:
Posts (Atom)

